Author

Fawzy A. El-Messallamy

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Empagliflozin’s role in cardiometabolic disease treatment: an Egyptian expert’s view

Given the expanding therapeutic indications of empagliflozin (EMPA) beyond glycemic control and the growing burden of cardiometabolic diseases, this review evaluated its efficacy, safety, and cost-effectiveness in the Egyptian population within the global context. A comprehensive literature review of PubMed and Google...

S. H. Assaad-Khalil, Fawzy Elmessallamy, K. E. Elhadidy et al. · Diabetology & Metabolic Synd... · 0 citations

Open access Aug 2026

Evaluation of sirtuin 1 serum level and gene expression in patients with metabolic syndrome accompanied by metabolic dysfunction-associated steatotic liver disease

Metabolic syndrome is a cluster of conditions, including abdominal obesity, dyslipidemia, hypertension, and impaired glucose metabolism, that significantly increase the risk of cardiovascular disease and type 2 diabetes mellitus (T2DM). Metabolic dysfunction-associated steatotic liver disease (MASLD) was recently intro...

Fawzy A. El-Messallamy, Mayada M. Mousa, Ahmad Sallam Soliman et al. · The Egyptian Journal of Inte... · 0 citations